CellaVision AB (publ) (STO:CEVI)
Sweden · Delayed Price · Currency is SEK 199.80
+8.80 (4.61%)
Nov 4, 2026, 5:29 PM CET
CellaVision AB Market Cap
CellaVision AB has a market cap or net worth of 4.77 billion as of November 4, 2026. It is the 14,763rd most valuable company in the world and the 191st biggest in Sweden. Its market cap has increased by 9.90% in one year.
Market Cap
4.77B
Enterprise Value
4.60B
Revenue
763.02M
Global Rank
Country Rank
#191 Sweden
PE Ratio
34.55
ChartMarket Cap Chart
Since May 28, 2007, CellaVision AB's market cap has increased from 372.09M to 4.77B, an increase of 1,180.74%. That is a compound annual growth rate of 14.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 4.77B | 27.10% |
| Dec 30, 2025 | 3.75B | -27.72% |
| Dec 30, 2024 | 5.19B | 2.59% |
| Dec 29, 2023 | 5.06B | -7.42% |
| Dec 30, 2022 | 5.46B | -29.58% |
| Dec 30, 2021 | 7.76B | 5.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elekta AB | 23.74B |
| Vitrolife AB | 15.62B |
| Nolato AB | 13.95B |
| MedCap AB | 8.31B |
| Xvivo Perfusion AB | 6.21B |
| BICO Group AB | 1.69B |
| Paxman AB | 1.46B |
| Devyser Diagnostics AB | 1.08B |